Ibaraki, Japan

Hideaki Morishige

This inventor holds 2 USPTO granted patents. Top assignee: Tsumura Co., Ltd.. Active years: 2000-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideaki Morishige. Retrieved from https://idiyas.com/inventor/hideaki-morishige

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2000-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Hideaki Morishige in Neovascularization Inhibitors

Introduction

Hideaki Morishige, an accomplished inventor based in Ibaraki, Japan, has made significant contributions to the field of medicinal chemistry. With a total of two patents to his name, Morishige is recognized for his innovative work on iridoid derivatives and their application in inhibiting neovascularization. His background and ongoing research have established him as a prominent figure in the pharmaceutical industry.

Latest Patents

Among his notable patents, the latest focuses on "Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient." This novel approach utilizes iridoid derivatives represented by a general formula, showcasing Morishige's dedication to advancing therapeutic options in the treatment of conditions associated with abnormal blood vessel formation.

Career Highlights

Morishige is affiliated with Tsumura & Co., an organization that specializes in herbal medicine and natural products. His work within the company reflects a commitment to harnessing the therapeutic potential of natural compounds, contributing to both innovation and patient care.

Collaborations

Throughout his career, Hideaki Morishige has collaborated with esteemed colleagues such as Yukiko Kurita and Yousuke Yamazaki. These collaborations foster an environment of shared knowledge and expertise, enhancing the innovative processes within their research initiatives.

Conclusion

In conclusion, Hideaki Morishige stands out as a notable inventor in the realm of iridoid derivatives and neovascularization inhibitors. His work at Tsumura & Co., combined with his collaborative efforts, underscores his contributions to the scientific community. Morishige's ongoing innovations promise to advance our understanding and treatment of various medical conditions related to neovascularization.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…